Crucial results for corona vaccination strategy

Empa researcher Peter Wick, Head of the Particles-Biology Interactions Laboratory in St. Gallen and Director of contactpointnano.ch talks to Empa Quarterly about recent antibody studies, which are crucial for the development of a COVID-19 vaccine, and the next generation of textile protective materials that inactivate or even kill corona viruses.

You can read the full article here.

Related articles

Pigments are Nano A webinar by contactpointnano.ch Nanomaterials are something new and innovative, right? Not necessarily: Certain nanomaterials were already in use in the Stone Age, long before mankind invented
Nanomedicine: The Minuten... Tiny particles that can fight cancer or that can easily pass through any interface within our body are a great promise for medicine. But there is little
Swiss NanoConvention 2020
Reliable knowledge on nan... contactpointnano.ch helps with questions about nanomaterials A new contact point for start-ups, SMEs and industry bundles the scientific and regulatory expertise in the field of nanotechnology available
Biointerfaces
Microplastics and Nanopla... Recently, the European Commission published a study that provides further information on the intentional uses of microplastic particles in products and the risks they pose to human
Webinar: Open questions a... Face masks characterize the public spaces today. Together with other measures, such as social distancing, hand hygiene and contact tracing, masks actively contribute to fight the spread
Guidelines: Safe-by-desig... A novel guideline document elaborated by the EU-consortium GoNanoBioMat and presented at the final dissemination event. The GoNanoBioMat framework is designed to elaborate current knowledge to small and medium-sized enterprises
Medical Device Regulation... Join us on December 14, 2020 for contactpointnano.ch‘s second webinar and learn about how to navigate new regulations for medical devices and new requirements regarding nanomaterials. Time: 13.00
Subscribe to our newslett... Like to be kept up to date? Sign up to our bi-monthly newsletter here!